0001209191-21-039590.txt : 20210610
0001209191-21-039590.hdr.sgml : 20210610
20210610173757
ACCESSION NUMBER: 0001209191-21-039590
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210608
FILED AS OF DATE: 20210610
DATE AS OF CHANGE: 20210610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: APPLE ROBERT F
CENTRAL INDEX KEY: 0001054942
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32302
FILM NUMBER: 211009168
MAIL ADDRESS:
STREET 1: C/O INKLINE PHARMACEUTICAL CO INC
STREET 2: SENTRY PARK EAST 1720 WALTON ROAD
CITY: BLUE BELL
STATE: PA
ZIP: 19422
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANTARES PHARMA, INC.
CENTRAL INDEX KEY: 0001016169
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411350192
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
BUSINESS PHONE: 609-359-3020
MAIL ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20060120
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20020520
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/
DATE OF NAME CHANGE: 20010604
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-08
0
0001016169
ANTARES PHARMA, INC.
ATRS
0001054942
APPLE ROBERT F
C/O ANTARES PHARMA, INC.
100 PRINCETON SOUTH, SUITE 300
EWING
NJ
08628
1
1
0
0
President & CEO
Common Stock
2021-06-08
4
F
0
44223
4.39
D
2246970
D
Represents the payment of tax liability using a portion of securities received from the company in connection with the vesting of a previously granted restricted stock unit award. The shares of common stock reported herein were withheld by the company to cover tax liability and not actually sold.
/s/Lisa M. Kallebo as attorney-in-fact for Robert F. Apple
2021-06-10
EX-24.4_991912
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that I, Robert F. Apple, hereby constitute
and appoint Fred M. Powell, Peter J. Graham, Lisa M. Kallebo and Keith
Muckenhirn, each of them, my true and lawful attorneys-in-fact and agents, each
acting alone, with full powers of substitution and resubstitution for me and in
my name, place and stead, to sign any reports on Form 3 (Initial Statement of
Beneficial Ownership), Form 4 (Statement of Changes in Beneficial Ownership of
Securities) and Form 5 (Annual Statement of Changes in Beneficial Ownership)
relating to transactions by me in Common Stock or other securities of Antares
Pharma, Inc., and all amendments thereto, and to file the same with the
Securities and Exchange Commission and appropriate securities listing agency, if
required, granting unto said attorneys-in-fact and agents, and each of them, or
their substitutes, full power and authority to do and perform each and every act
and thing requisite or necessary to be done, as fully to all intents and
purposes as I might or could do in person, hereby ratifying and confirming all
that said attorneys-in-fact and agents, and each of them, or their substitutes,
may lawfully do or cause to be done by virtue hereof. This Power of Attorney
shall be effective until such time as I deliver a written revocation thereof to
my above-named attorneys-in-fact and agents.
/s/ Robert F. Apple
Dated: June 8, 2021